(4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid (BioDeep_00000172639)

   

human metabolite blood metabolite


代谢物信息卡片


2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid

化学式: C19H22ClNO4 (363.1237282000001)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 25%

分子结构信息

SMILES: CC(CC1=CC=C(C=C1)OCC(=O)O)NCC(C2=CC(=CC=C2)Cl)O
InChI: InChI=1S/C19H22ClNO4/c1-13(21-11-18(22)15-3-2-4-16(20)10-15)9-14-5-7-17(8-6-14)25-12-19(23)24/h2-8,10,13,18,21-22H,9,11-12H2,1H3,(H,23,24)

描述信息

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

同义名列表

10 个代谢物同义名

2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid; 2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetate; Sodium 2-(4-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetate; 2-[4-(2-{[2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)phenoxy]acetic acid; (4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid; 4-(2-{[2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)phenoxyacetic acid; 2-[4-(2-{[2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)phenoxy]acetate; (4-(2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetate; BRL 37344, (R*,r*)-(+-)-isomer; BRL-37344 Sodium



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Yun Xing, Tian Tian, Xue Zhang, Duomeng Yang, Chanjuan Zhang, Miao Wang, Yiyang Wang, Tao Luo, Zhi Wang, Huadong Wang, Hongmei Li. ENDOGENOUS β 3 -ADRENERGIC RECEPTOR ACTIVATION ALLEVIATES SEPSIS-INDUCED CARDIOMYOCYTE APOPTOSIS VIA PI3K/AKT SIGNALING PATHWAY. Shock (Augusta, Ga.). 2024 Jun; 61(6):915-923. doi: 10.1097/shk.0000000000002354. [PMID: 38662592]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Andrzej Wróbel, Barbara Miziak, Małgorzata Bańczerowska-Górska, Aleksandra Szopa, Anna Serefko, Klaudia Stangel-Wójcikiewicz, Piotr Czuczwar, Marzena Laskowska, Edyta Wlaźlak, Jarosław Dudka, Ewa Poleszak. The influence of nebivolol on the activity of BRL 37344 - the β3-adrenergic receptor agonist, in the animal model of detrusor overactivity. Neurourology and urodynamics. 2019 06; 38(5):1229-1240. doi: 10.1002/nau.23993. [PMID: 30937955]
  • Katarzyna Grzelka, Maciej Gawlak, Katarzyna Czarzasta, Paweł Szulczyk. Effects of β3-adrenergic receptor stimulation on the resting holding current of medial prefrontal cortex pyramidal neurons in young rats. Neuroscience letters. 2019 04; 698(?):192-197. doi: 10.1016/j.neulet.2019.01.022. [PMID: 30641111]
  • Andrzej Wróbel, Tomasz Rechberger. The effect of combined treatment with a β3 AR agonist and a ROCK inhibitor on detrusor overactivity. Neurourology and urodynamics. 2017 03; 36(3):580-588. doi: 10.1002/nau.22978. [PMID: 26879338]
  • Giuseppe Procino, Monica Carmosino, Serena Milano, Massimo Dal Monte, Giorgia Schena, Maria Mastrodonato, Andrea Gerbino, Paola Bagnoli, Maria Svelto. β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function. Kidney international. 2016 09; 90(3):555-67. doi: 10.1016/j.kint.2016.03.020. [PMID: 27206969]
  • Hala Abdel Malek, A Shalaby. The preventive effect of β3 adrenoceptor stimulation against experimentally induced reflux esophagitis. Acta physiologica Hungarica. 2015 Mar; 102(1):94-104. doi: 10.1556/aphysiol.102.2015.1.10. [PMID: 25804391]
  • Danielle M Trappanese, Yuchuan Liu, Ryan C McCormick, Alessandro Cannavo, Gayani Nanayakkara, Marina M Baskharoun, Harish Jarrett, Felix J Woitek, D Michael Tillson, A Ray Dillon, Fabio A Recchia, Jean-Luc Balligand, Steven R Houser, Walter J Koch, Louis J Dell'Italia, Emily J Tsai. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy. Basic research in cardiology. 2015 Jan; 110(1):456. doi: 10.1007/s00395-014-0456-3. [PMID: 25480109]
  • Zhao-hong Wang, Yan-fang Li, Yan-qing Guo. β3-Adrenoceptor activation attenuates atherosclerotic plaque formation in ApoE(-/-) mice through lowering blood lipids and glucose. Acta pharmacologica Sinica. 2013 Sep; 34(9):1156-63. doi: 10.1038/aps.2013.70. [PMID: 23892270]
  • Signe Mølhøj Jensen, Harald S Hansen, Thue Johansen, Kjell Malmlöf. In vivo and in vitro microdialysis sampling of free fatty acids. Journal of pharmaceutical and biomedical analysis. 2007 Apr; 43(5):1751-6. doi: 10.1016/j.jpba.2006.12.014. [PMID: 17240099]
  • C Ferrand, A Redonnet, D Prévot, C Carpéné, C Atgié. Prolonged treatment with the beta3-adrenergic agonist CL 316243 induces adipose tissue remodeling in rat but not in guinea pig: 1) fat store depletion and desensitization of beta-adrenergic responses. Journal of physiology and biochemistry. 2006 Jun; 62(2):89-99. doi: 10.1007/bf03174070. [PMID: 17217163]
  • J Krcmár, H Kotolová, L Veselá, J Csöllei, T Gonec, M Karpísek, L Bartosová, J Necas. [Study of a newly synthesized substance with a potential to stimulate beta3-adrenergic receptors]. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 2006 May; 55(3):120-3. doi: NULL. [PMID: 16838489]
  • Atso Raasmaja, David A York. Pharmacological characterization of alpha1- and beta-adrenergic synergism of 5'DII activity in rat brown adipocytes. Archives of physiology and biochemistry. 2006 Feb; 112(1):23-30. doi: 10.1080/13813450500500464. [PMID: 16754200]
  • Natalie R Lenard, Adrian J Dunn. Potential role for nonesterified fatty acids in beta-adrenoceptor-induced increases in brain tryptophan. Neurochemistry international. 2005 Jan; 46(2):179-87. doi: 10.1016/j.neuint.2004.07.010. [PMID: 15627518]
  • J L Verago, D M Grassi-Kassisse, R C Spadari-Bratfisch. Metabolic markers following beta-adrenoceptor agonist infusion in footshock-stressed rats. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2001 Sep; 34(9):1197-207. doi: 10.1590/s0100-879x2001000900014. [PMID: 11514845]
  • E Herrera, E Amusquivar, J Cacho. Changes in dietary fatty acids modify the decreased lipolytic beta3-adrenergic response to hyperinsulinemia in adipocytes from pregnant and nonpregnant rats. Metabolism: clinical and experimental. 2000 Sep; 49(9):1180-7. doi: 10.1053/meta.2000.8618. [PMID: 11016901]
  • E Farias-Silva, D M Grassi-Kassisse, V Wolf-Nunes, R C Spadari-Bratfisch. Stress-induced alteration in the lipolytic response to beta-adrenoceptor agonists in rat white adipocytes. Journal of lipid research. 1999 Sep; 40(9):1719-27. doi: 10.1016/s0022-2275(20)33419-2. [PMID: 10484620]
  • P P Vicario, M R Candelore, M T Schaeffer, L Kelly, G M Thompson, E J Brady, R Saperstein, D E MacIntyre, L M Tota, M A Cascieri. Desensitization of beta3-adrenergic receptor-stimulated adenylyl cyclase activity and lipolysis in rats. Life sciences. 1998; 62(7):627-38. doi: 10.1016/s0024-3205(97)01158-2. [PMID: 9472722]
  • T W Gettys, P M Watson, I L Taylor, S Collins. RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient beta-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob mice. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 1997 Oct; 21(10):865-73. doi: 10.1038/sj.ijo.0800479. [PMID: 9347404]
  • C Atgié, F D'Allaire, L J Bukowiecki. Role of beta1- and beta3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes. The American journal of physiology. 1997 10; 273(4):C1136-42. doi: 10.1152/ajpcell.1997.273.4.c1136. [PMID: 9357756]
  • T Tanishita, Y Shimizu, Y Minokoshi, T Shimazu. The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin. Journal of biochemistry. 1997 Jul; 122(1):90-5. doi: 10.1093/oxfordjournals.jbchem.a021744. [PMID: 9276675]
  • K E Hadri, C Charon, J Pairault, S Hauguel-De Mouzon, A Quignard-Boulangé, B Fève. Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin. The Biochemical journal. 1997 Apr; 323 ( Pt 2)(?):359-64. doi: 10.1042/bj3230359. [PMID: 9163324]
  • K Ida, K Hashimoto, M Kamiya, S Muto, Y Nakamura, K Kato, M Mizota. Stereoselective action of (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2-(3-chlorophenyl)ethylamino] propyl]-phenoxyacetic acid (BRL37344) on beta-adrenoceptors and metabolic chiral inversion. Biochemical pharmacology. 1996 Nov; 52(10):1521-7. doi: 10.1016/s0006-2952(96)00551-5. [PMID: 8937466]
  • A J Hoey, C M Jackson, G G Pegg, M N Sillence. Characteristics of cyanopindolol analogues active at the beta 3-adrenoceptor in rat ileum. British journal of pharmacology. 1996 Oct; 119(3):564-8. doi: 10.1111/j.1476-5381.1996.tb15709.x. [PMID: 8894179]
  • C Deng, A Paoloni-Giacobino, F Kuehne, O Boss, J P Revelli, M Moinat, M A Cawthorne, P Muzzin, J P Giacobino. Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues. British journal of pharmacology. 1996 Jun; 118(4):929-34. doi: 10.1111/j.1476-5381.1996.tb15488.x. [PMID: 8799564]
  • M Reverte, L Rivas-Cabañero. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits. Canadian journal of physiology and pharmacology. 1996 Mar; 74(3):251-6. doi: 10.1139/y96-015. [PMID: 8773403]
  • M P Portillo, A S Del Barrio, M A Garcia-Calonge, J A Martinez. Desensitization effect of in vivo treatment with metaproterenol on beta1, beta2 and beta3-adrenergic responsiveness in rat adipocytes. Life sciences. 1996; 58(5):405-14. doi: 10.1016/0024-3205(95)02305-4. [PMID: 8594305]
  • X M Guan, A Amend, C D Strader. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor. Molecular pharmacology. 1995 Sep; 48(3):492-8. doi: NULL. [PMID: 7565630]
  • T W Gettys, E M Rohlfs, V Prpic, K W Daniel, I L Taylor, S Collins. Age-dependent changes in beta-adrenergic receptor subtypes and adenylyl cyclase activation in adipocytes from Fischer 344 rats. Endocrinology. 1995 May; 136(5):2022-32. doi: 10.1210/endo.136.5.7720650. [PMID: 7720650]
  • S Klaus, P Muzzin, J P Revelli, M A Cawthorne, J P Giacobino, D Ricquier. Control of beta 3-adrenergic receptor gene expression in brown adipocytes in culture. Molecular and cellular endocrinology. 1995 Apr; 109(2):189-95. doi: 10.1016/0303-7207(95)03502-x. [PMID: 7664982]
  • J A Dolan, H A Muenkel, M G Burns, S M Pellegrino, C M Fraser, F Pietri, A D Strosberg, E E Largis, M D Dutia, J D Bloom. Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. The Journal of pharmacology and experimental therapeutics. 1994 Jun; 269(3):1000-6. doi: NULL. [PMID: 7912272]
  • R Bertin, F de Marco, G Blancher, R Portet. [Functional exploration of brown adipose tissue using beta3 agonists]. Bulletin de l'Academie nationale de medecine. 1994 Jun; 178(6):1155-65. doi: ". [PMID: 7994586]
  • M Reverte, J Moratinos. Effects of salbutamol and BRL 37344 on diastolic arterial blood pressure, plasma glucose and plasma lactate in rabbits. Fundamental & clinical pharmacology. 1994; 8(5):417-24. doi: 10.1111/j.1472-8206.1994.tb00820.x. [PMID: 7875635]
  • L Casteilla, P Muzzin, J P Revelli, D Ricquier, J P Giacobino. Expression of beta 1- and beta 3-adrenergic-receptor messages and adenylate cyclase beta-adrenergic response in bovine perirenal adipose tissue during its transformation from brown into white fat. The Biochemical journal. 1994 Jan; 297 ( Pt 1)(?):93-7. doi: 10.1042/bj2970093. [PMID: 7904157]
  • H Abe, Y Minokoshi, T Shimazu. Effect of a beta 3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro. The Journal of endocrinology. 1993 Dec; 139(3):479-86. doi: 10.1677/joe.0.1390479. [PMID: 7907647]
  • N Fraeyman, A Van Ermen, E Van de Velde, P Vanscheeuwijck. Pharmacological characterization of a beta 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177A) in neonatal rat liver plasma membranes. Biochemical pharmacology. 1992 Dec; 44(12):2333-8. doi: 10.1016/0006-2952(92)90677-b. [PMID: 1361733]
  • D Langin, M P Portillo, J S Saulnier-Blache, M Lafontan. Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species. European journal of pharmacology. 1991 Jul; 199(3):291-301. doi: 10.1016/0014-2999(91)90492-9. [PMID: 1680716]
  • P Muzzin, J Seydoux, J P Giacobino, J C Venter, C Fraser. Discrepancies between the affinities of binding and action of the novel beta-adrenergic agonist BRL 37344 in rat brown adipose tissue. Biochemical and biophysical research communications. 1988 Oct; 156(1):375-82. doi: 10.1016/s0006-291x(88)80851-9. [PMID: 2902858]